CureVac’s pain may not yet have peaked

  • 📰 Reuters
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

From Breakingviews: CureVac’s value halved to $10 billion after it said its COVID-19 vaccine may only be 47% effective. Separate trials on its cancer vaccine will be key to the German drugmaker’s future health, writes aimeedonnellan

to fight Covid-19 – the latter’s share price has jumped 10-fold since before the pandemic last year. But the technology behind them is very new.

The optimistic scenario for CureVac Chief Executive Franz-Werner Haas is that something other than his core mRNA technology is the culprit. CureVac’s decision not to use a chemical called uridine to boost the mRNA’s duration in the body may explain its less effective vaccine. If so, and if CureVac’s cancer vaccine trials are more positive, then Jefferies analysts reckon the company’s shares could rebound from $49 to $80.

The real doomsday scenario for Haas is if CureVac’s mRNA has flaws. Jefferies reckons fair value following the vaccine revelations is around $45 per share, but mRNA technology accounts for $40 a share. If the cancer vaccine fails, the analyst reckons it could be worth as little as $14 a share. Until those results come in, investors will be on tenterhooks.- German biotechnology company CureVac said on June 16 that its Covid-19 vaccine was only 47% effective in a late-stage trial.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

veltcardio Acá se enteraron y van a pedir 6 millones de dosis 😆

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

German business lobby group defends its mocking of Greens leaderA German business lobby group on Tuesday defended a controversial campaign in which it portrays Greens chancellor candidate Annalena Baerbock dressed as a biblical Moses, holding two tablets under the caption 'Annalena and the 10 bans.'
Source: Reuters - 🏆 2. / 97 Read more »

CureVac shares tank 50% after preliminary data shows Covid vaccine is only 47% effectiveThe late-stage clinical trial found high prevalence of virus variants. Lmao They don’t even need to bother rolling it out at this point 47%?!
Source: CNBC - 🏆 12. / 72 Read more »

CureVac says its COVID vaccine was poor match against 29 COVID variants, as global case tally tops 177 millionThe global tally of confirmed cases of COVID-19 climbed above 177 million on Thursday, a day after disappointing news from CureVac with the German company... Oh no
Source: MarketWatch - 🏆 3. / 97 Read more »

Covid-19: Bedford's declining rate down to 'surge testing and jabs'The infection rate in Bedford has fallen but a councillor warns: 'We're not out of the woods yet'.
Source: bbchealth - 🏆 143. / 63 Read more »

When Does a Pounding Headache Actually Signal a Brain Tumor?If the pain is unmanageable or just feels unusual for you, don’t blow it off. Brain tumors are not “incredibly rare”as stated in this article. Publishing this calls your publication into question. We can no longer endorse you as a trusted source.
Source: PreventionMag - 🏆 141. / 63 Read more »